These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 33989894

  • 1. Immunity to EBV as revealed by immunedeficiencies.
    Fournier B, Latour S.
    Curr Opin Immunol; 2021 Oct; 72():107-115. PubMed ID: 33989894
    [Abstract] [Full Text] [Related]

  • 2. Signaling pathways involved in the T-cell-mediated immunity against Epstein-Barr virus: Lessons from genetic diseases.
    Latour S, Fischer A.
    Immunol Rev; 2019 Sep; 291(1):174-189. PubMed ID: 31402499
    [Abstract] [Full Text] [Related]

  • 3. Increased frequency of EBV-specific effector memory CD8+ T cells correlates with higher viral load in rheumatoid arthritis.
    Lünemann JD, Frey O, Eidner T, Baier M, Roberts S, Sashihara J, Volkmer R, Cohen JI, Hein G, Kamradt T, Münz C.
    J Immunol; 2008 Jul 15; 181(2):991-1000. PubMed ID: 18606650
    [Abstract] [Full Text] [Related]

  • 4. Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells.
    Albanese M, Tagawa T, Bouvet M, Maliqi L, Lutter D, Hoser J, Hastreiter M, Hayes M, Sugden B, Martin L, Moosmann A, Hammerschmidt W.
    Proc Natl Acad Sci U S A; 2016 Oct 18; 113(42):E6467-E6475. PubMed ID: 27698133
    [Abstract] [Full Text] [Related]

  • 5. Increased T-cell responses to Epstein-Barr virus with high viral load in patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma.
    Morishima S, Nakamura S, Yamamoto K, Miyauchi H, Kagami Y, Kinoshita T, Onoda H, Yatabe Y, Ito M, Miyamura K, Nagai H, Moritani S, Sugiura I, Tsushita K, Mihara H, Ohbayashi K, Iba S, Emi N, Okamoto M, Iwata S, Kimura H, Kuzushima K, Morishima Y.
    Leuk Lymphoma; 2015 Apr 18; 56(4):1072-8. PubMed ID: 24975317
    [Abstract] [Full Text] [Related]

  • 6. Cytomegalovirus-seropositive children show inhibition of in vitro EBV infection that is associated with CD8+CD57+ T cell enrichment and IFN-γ.
    Sohlberg E, Saghafian-Hedengren S, Rasul E, Marchini G, Nilsson C, Klein E, Nagy N, Sverremark-Ekström E.
    J Immunol; 2013 Dec 01; 191(11):5669-76. PubMed ID: 24140645
    [Abstract] [Full Text] [Related]

  • 7. The interplay between Epstein-Barr virus and B lymphocytes: implications for infection, immunity, and disease.
    Hatton OL, Harris-Arnold A, Schaffert S, Krams SM, Martinez OM.
    Immunol Res; 2014 May 01; 58(2-3):268-76. PubMed ID: 24619311
    [Abstract] [Full Text] [Related]

  • 8. Severe Epstein-Barr virus infection in primary immunodeficiency and the normal host.
    Worth AJ, Houldcroft CJ, Booth C.
    Br J Haematol; 2016 Nov 01; 175(4):559-576. PubMed ID: 27748521
    [Abstract] [Full Text] [Related]

  • 9. CD4+ T-cell effectors inhibit Epstein-Barr virus-induced B-cell proliferation.
    Nikiforow S, Bottomly K, Miller G.
    J Virol; 2001 Apr 01; 75(8):3740-52. PubMed ID: 11264363
    [Abstract] [Full Text] [Related]

  • 10. Activating PIK3CD mutations impair human cytotoxic lymphocyte differentiation and function and EBV immunity.
    Edwards ESJ, Bier J, Cole TS, Wong M, Hsu P, Berglund LJ, Boztug K, Lau A, Gostick E, Price DA, O'Sullivan M, Meyts I, Choo S, Gray P, Holland SM, Deenick EK, Uzel G, Tangye SG.
    J Allergy Clin Immunol; 2019 Jan 01; 143(1):276-291.e6. PubMed ID: 29800648
    [Abstract] [Full Text] [Related]

  • 11. The Epstein-Barr Virus Oncogene EBNA1 Suppresses Natural Killer Cell Responses and Apoptosis Early after Infection of Peripheral B Cells.
    Westhoff Smith D, Chakravorty A, Hayes M, Hammerschmidt W, Sugden B.
    mBio; 2021 Dec 21; 12(6):e0224321. PubMed ID: 34781735
    [Abstract] [Full Text] [Related]

  • 12. CD27 is required for protective lytic EBV antigen-specific CD8+ T-cell expansion.
    Deng Y, Chatterjee B, Zens K, Zdimerova H, Müller A, Schuhmachers P, Ligeon LA, Bongiovanni A, Capaul R, Zbinden A, Holler A, Stauss H, Hammerschmidt W, Münz C.
    Blood; 2021 Jun 10; 137(23):3225-3236. PubMed ID: 33827115
    [Abstract] [Full Text] [Related]

  • 13. When to suspect inborn errors of immunity in Epstein-Barr virus-related lymphoproliferative disorders.
    Sacco KA, Notarangelo LD, Delmonte OM.
    Clin Microbiol Infect; 2023 Apr 10; 29(4):457-462. PubMed ID: 36209991
    [Abstract] [Full Text] [Related]

  • 14. Inherited Immunodeficiencies With High Predisposition to Epstein-Barr Virus-Driven Lymphoproliferative Diseases.
    Latour S, Winter S.
    Front Immunol; 2018 Apr 10; 9():1103. PubMed ID: 29942301
    [Abstract] [Full Text] [Related]

  • 15. Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products.
    Ressing ME, Horst D, Griffin BD, Tellam J, Zuo J, Khanna R, Rowe M, Wiertz EJ.
    Semin Cancer Biol; 2008 Dec 10; 18(6):397-408. PubMed ID: 18977445
    [Abstract] [Full Text] [Related]

  • 16. Genetic susceptibility to EBV infection: insights from inborn errors of immunity.
    Tangye SG.
    Hum Genet; 2020 Jun 10; 139(6-7):885-901. PubMed ID: 32152698
    [Abstract] [Full Text] [Related]

  • 17. Mice with Reconstituted Human Immune System Components as a Tool to Study Immune Cell Interactions in EBV Infection.
    Heuts F, Nagy N.
    Methods Mol Biol; 2017 Jun 10; 1532():229-240. PubMed ID: 27873280
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Rapid reconstitution of Epstein-Barr virus-specific T lymphocytes following allogeneic stem cell transplantation.
    Marshall NA, Howe JG, Formica R, Krause D, Wagner JE, Berliner N, Crouch J, Pilip I, Cooper D, Blazar BR, Seropian S, Pamer EG.
    Blood; 2000 Oct 15; 96(8):2814-21. PubMed ID: 11023516
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.